Approval · Notice of Compliance 2748 · 1998
PLAVIX: Notice of Compliance 2748
Issued October 7, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2748
- Date
- October 7, 1998
- Company
- Sanofi Canada, Inc.Markham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Platelet aggregation inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PLAVIX | 02238682 | Marketed |
Medicinal ingredients
- CLOPIDOGREL BISULFATE 75 MG per TAB